Comparison of time-of-flight mass spectrometry to triple quadrupole tandem mass spectrometry for quantitative bioanalysis: Application to antipsychotics

Journal of Liquid Chromatography and Related Technologies

Volumn 31, Issue 18, 2008, Pages 2737-2751

  Williamson, Leah N ^a   Zhang, Guodong ^a   Terry Jr , Alvin V ^b   Bartlett, Michael G ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Antipsychotics; LC MS; Method validation; Time of flight mass spectrometry

Indexed keywords

ARSENIC COMPOUNDS; CHLORINE COMPOUNDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INDUCTIVELY COUPLED PLASMA; LINEARIZATION; MASS SPECTROMETRY; NEGATIVE IONS; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; STANDARDS;

AND RECOVERY; ANTIPSYCHOTICS; BIO-ANALYSIS; BIOLOGICAL SAMPLES; CLOZAPINE; HIGH SPECIFICITY; INTERNAL STANDARD; LC-MS; LC-MS/MS; MASS ANALYZERS; MASS DETERMINATION; MATRIX EFFECTS; METHOD VALIDATION; MIDAZOLAM; OLANZAPINE; RAT PLASMAS; RISPERIDONE; SMALL MOLECULES; TANDEM MASS SPECTROMETRY; TIME -OF-FLIGHT; TIME OF FLIGHT-MASS SPECTROMETERS; TIME-OF-FLIGHT MASS SPECTROMETRY; TRIPLE QUADRUPOLE; TRIPLE QUADRUPOLE TANDEM MASS SPECTROMETRY;

MASS SPECTROMETERS;

CLOZAPINE; HALOPERIDOL; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDOL; RISPERIDONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

RATTUS;

EID: 52449125833     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070802388243     Document Type: Article

References (18)

1. Srinivas, N.R. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations. Biomed. Chromatogr. 2006, 20, 383-414.
2. Williamson, L.N.; Bartlett, M.G. Quantitative liquid chromatography/ time-of-flight mass spectrometry. Biomed. Chromatogr. 2007, 21, 567-576.
3. Williamson, L.N.; Bartlett, M.G. Quantitative gas chromatography/time-of- flight mass spectrometry: A review. Biomed. Chromatogr. 2007, 21, 664-669.
4. Zhang, N.; Fountain, S.T.; Bi, H.; Rossi, D.T. Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS. Anal. Chem. 2000, 72, 800-806.
5. Zhang, H.; Henion, J. Comparison between liquid chromatography-time of-flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma. J. Chromatogr. B. 2001, 757, 151-159.
6. Nunez, O.; Moyano, E.; Galceran, M.T. Time-of-flight high resolution versus triple quadrupole tandem mass spectrometry for the analysis of quaternary ammonium herbicides in drinking water. Anal. Chim. Acta. 2004, 525, 183-190.
7. Ereshefsky, L. Pharmacokinetics and drug interactions: Update for new antipsychotics. J. Clin. Psych. 1996, 57, Suppl 11, 12-25.
8. Olesen, O.V.; Linnet, K. Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication. Therapeut. Drug Monit. 1999, 21, 87-90.
9. Raggi, M.A. Therapeutic drug monitoring: chemical-clinical correlations of atypical antipsychotic drugs. Cur. Med. Chem. 2002, 9, 1397-1349.
10. Gex-Fabry, M.; Balant-Gorgia, A.E.; Balant, L.P. Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication. Therapeut. Drug Monit. 2003, 25, 46-53.
11. Terry, Jr., A.V.; Parikh, V.; Gearhart, D.A.; Pillai, A.; Hohnadel, E.; Warner, S.; Nasrallah, H.A.; Mahadik, S.P. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. J. Pharmacol. Exp. Therapeut. 2006, 318, 709-724.
12. Terry, Jr., A.V.; Gearhart, D.A.; Warner, S.E.; Hohnadel, E.J.; Middlemore, M.-L.; Zhang, G.; Bartlett, M.G.; Mahadik, S.P. Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons and spatial learning in rats. Neuroscience. 2007, 150, 413-424.
13. Terry, Jr., A.V.; Gearhart, D.A.; Mahadik, S.P.; Warsi, S.; Waller, J.L. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Neuroscience. 2006, 140, 1277-1287.
14. Parikh, V.; Terry, Jr., A.V.; Khan, M.M.; Mahadik, S.P. Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine. Psychopharmacol. (Berl). 2004, 172, 365-374.
15. Zhang, G.; Terry, Jr., A.V.; Bartlett, M.G. Liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat plasma. Rapid Commun. Mass Spectrom. 2007, 21, 920-928.
16. Zhang, G.; Terry, Jr., A.V.; Bartlett, M.G. Sensitive liquid chromatography/ tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue. J. Chromatogr. B. 2007, 858, 276-281.
17. Zhang, G.; Terry, Jr., A.V.; Bartlett, M.G. Sensitive liquid chromatography/ tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue. J. Chromatogr. B. 2007, 854, 68-76.
18. Matuszewski, B.K.; Constanzer, M.L.; Chavez-Eng, C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75, 3019-3030.